Inbrain Neuroelectronics signed a pact with Microsoft to use the tech giant’s Azure AI infrastructure to advance the Spanish ...

The partners aim to develop AI-powered, real-time, personalized brain-computer interface therapies for neurological disorders ...

Researchers in Shanghai have reported in a study, recently published in Science Advances, that they've successfully decoded ...

Synchron Funding will advance commercialization of the Stentrode™ BCI platform and expand AI and engineering operations in New York and San Diego The round was led by Double Point Ventures, alongside ...

The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials ...

INBRAIN partners with Microsoft to use agentic AI and Azure cloud tech for next-gen brain-computer therapeutics.

INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced a strategic collaboration with Microsoft to explore ...

Cognixion’s Vision Pro study shows how Apple’s accessibility framework is shaping the future of healthcare and communication ...

A neural interface framework integrating L2 regularization with attention supervision paradigms achieves 96.87% classification accuracy in EEG ...

Remember how, last week, we talked about tech giant Microsoft ($MSFT) and its plans to get AI involved in medicine? Well, ...

Last month, a study showed Science Corp.’s PRIMA BCI retinal implant restored some vision to people with severe age-related macular degeneration. Meanwhile, Elon Musk’s Neuralink earlier this year ...

Australia has invested $54 million in Melbourne-born brain-computer interface company Synchron, the federal government’s National Reconstruction Fund Corporation (NRFC) announced on Thursday.